Aspire Biopharma names new executive chair

20 hours ago 1

Aspire Biopharma (NASDAQ:ASBP) said that Board of Directors has appointed Kraig Higginson as interim CEO, effective July 24, 2025.
Mr. Higginson serves as Chairman of the Board and previously served as CEO of Aspire for four years.
Michael C. Howe has resigned as CEO and as a member of the Board.
The company and plans to initiate a search for a permanent CEO.

Recommended For You